Home
CTMX
CTMX News

Latest CytomX Therapeutics Inc. (CTMX) News on July 27, 2024

CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?

Insider Monkey

2 days ago

CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company

Simply Wall St.

5 days ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

GlobeNewswire

a month ago

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire

a month ago

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago

Simply Wall St.

2 months ago

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

CytomX Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

2 months ago

CytomX Therapeutics Announces New Employment Inducement Grants

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

MT Newswires

3 months ago

BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating

Thomson Reuters StreetEvents

3 months ago

Q1 2024 CytomX Therapeutics Inc Earnings Call

MT Newswires

3 months ago

Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3

GuruFocus.com

3 months ago

CytomX Therapeutics Inc (CTMX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Associated Press Finance

3 months ago

CytomX Therapeutics: Q1 Earnings Snapshot

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

GlobeNewswire

3 months ago

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

GlobeNewswire

3 months ago

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

MT Newswires

3 months ago

Jefferies Upgrades CytomX Therapeutics to Buy, Price Target at $8

CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?

Zacks

3 months ago

CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

GlobeNewswire

3 months ago

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation

Simply Wall St.

3 months ago

Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

GlobeNewswire

4 months ago

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

GlobeNewswire

4 months ago

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

GlobeNewswire

4 months ago

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

GlobeNewswire

4 months ago

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 CytomX Therapeutics Inc Earnings Call

CytomX Therapeutics Inc (CTMX) Reports 2023 Financial Results and Provides Pipeline Update

GuruFocus.com

5 months ago

CytomX Therapeutics Inc (CTMX) Reports 2023 Financial Results and Provides Pipeline Update

CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates

Zacks

5 months ago

CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

GlobeNewswire

5 months ago

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

CytomX (CTMX) to Report Q4 Earnings: Here's What to Expect

Zacks

5 months ago

CytomX (CTMX) to Report Q4 Earnings: Here's What to Expect

CytomX Therapeutics to Present at Upcoming March Investor Conferences

GlobeNewswire

5 months ago

CytomX Therapeutics to Present at Upcoming March Investor Conferences

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) largest shareholders are retail investors with 50% ownership, institutions own 29%

Simply Wall St.

5 months ago

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) largest shareholders are retail investors with 50% ownership, institutions own 29%

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

NewMediaWire

6 months ago

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

Marine Products Corporation (NYSE:MPX) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Marine Products Corporation (NYSE:MPX) Q4 2023 Earnings Call Transcript

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

PR Newswire

6 months ago

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

BNY Mellon High Yield Strategies Fund Declares Dividend

Business Wire

6 months ago

BNY Mellon High Yield Strategies Fund Declares Dividend

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

GuruFocus.com

6 months ago

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

Zacks

6 months ago

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

Zacks

6 months ago

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

GlobeNewswire

6 months ago

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

Gran Tierra Energy Inc. Announces Strong Reserves Replacement and Meaningful Reserves Growth in 2023

GlobeNewswire

6 months ago

Gran Tierra Energy Inc. Announces Strong Reserves Replacement and Meaningful Reserves Growth in 2023

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal

Zacks

6 months ago

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

Zacks

6 months ago

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Zacks

6 months ago

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

PR Newswire

6 months ago

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Zacks

6 months ago

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

Zacks

6 months ago

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

Simply Wall St.

6 months ago

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

Genetron Health to Hold Extraordinary General Meeting of Shareholders

GlobeNewswire

6 months ago

Genetron Health to Hold Extraordinary General Meeting of Shareholders

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

Business Wire

6 months ago

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

QuickLogic (QUIK) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

6 months ago

QuickLogic (QUIK) Is a Great Choice for 'Trend' Investors, Here's Why

Innodata to Participate in Needham's 26th Annual Growth Conference

ACCESSWIRE

7 months ago

Innodata to Participate in Needham's 26th Annual Growth Conference

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Simply Wall St.

7 months ago

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer

Food Dive

7 months ago

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

7 months ago

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

FARO Successfully Completes SOC 2 Type II Audit

PR Newswire

7 months ago

FARO Successfully Completes SOC 2 Type II Audit

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

GlobeNewswire

7 months ago

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

Does Marine Products (NYSE:MPX) Deserve A Spot On Your Watchlist?

Simply Wall St.

7 months ago

Does Marine Products (NYSE:MPX) Deserve A Spot On Your Watchlist?

Should You Invest in Bluebird Bio Right Now?

Motley Fool

7 months ago

Should You Invest in Bluebird Bio Right Now?

Business Wire

7 months ago

Stratasys Adopts Limited Duration Shareholder Rights Plan with Enhanced Shareholder Protections

Zacks Small Cap Research

7 months ago

XFOR: Update on Phase 2 CN Trial at ASH 2023

Those who invested in Escalade (NASDAQ:ESCA) a year ago are up 110%

Simply Wall St.

7 months ago

Those who invested in Escalade (NASDAQ:ESCA) a year ago are up 110%

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

GlobeNewswire

7 months ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

PR Newswire

7 months ago

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

The five-year returns have been massive for Innodata (NASDAQ:INOD) shareholders despite underlying losses increasing

Simply Wall St.

7 months ago

The five-year returns have been massive for Innodata (NASDAQ:INOD) shareholders despite underlying losses increasing

Calculating The Intrinsic Value Of TrueCar, Inc. (NASDAQ:TRUE)

Simply Wall St.

8 months ago

Calculating The Intrinsic Value Of TrueCar, Inc. (NASDAQ:TRUE)

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

GlobeNewswire

8 months ago

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

Alto Ingredients, Inc. Extends Term Loan Commitment Period

GlobeNewswire

8 months ago

Alto Ingredients, Inc. Extends Term Loan Commitment Period

MYR Group Inc. to Attend Goldman Sachs Energy, CleanTech & Utilities Conference in January

GlobeNewswire

8 months ago

MYR Group Inc. to Attend Goldman Sachs Energy, CleanTech & Utilities Conference in January

L.B. Foster to Present at Sidoti and Singular Conferences; Updated Corporate Investor Presentation to be Posted Online

GlobeNewswire

8 months ago

L.B. Foster to Present at Sidoti and Singular Conferences; Updated Corporate Investor Presentation to be Posted Online

Adaptimmune Receives Transfer of IND for Lete-cel Program

Newsfile

8 months ago

Adaptimmune Receives Transfer of IND for Lete-cel Program

Business Wire

8 months ago

Western Asset Mortgage Opportunity Fund Inc. Announces Financial Position as of September 30, 2023

Allbirds begins selling on Amazon

Retail Dive

8 months ago

Allbirds begins selling on Amazon

Mondee Announces Acquisition of Leading AI Company Purplegrids

Business Wire

8 months ago

Mondee Announces Acquisition of Leading AI Company Purplegrids

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

GlobeNewswire

9 months ago

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

GlobeNewswire

9 months ago

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

Associated Press Finance

9 months ago

Sprott: Q3 Earnings Snapshot

Sprott Announces Third Quarter 2023 Results

GlobeNewswire

9 months ago

Sprott Announces Third Quarter 2023 Results

Share on Social Networks: